BACKGROUND: Data on the societal costs of mental disorders are necessary to inform health policies. METHODS: This study assessed the costs of panic disorder and subthreshold panic disorder, compared these with costs of other mental disorders, and assessed the effects of (psychiatric and somatic) comorbidity and agoraphobia on the costs of panic. Using a large, population-based study in The Netherlands (n=5504), both medical and production costs were estimated from a societal perspective within a one-year timeframe. RESULTS: Annual per capita costs of panic disorder were 10,269 euros, while subthreshold panic disorder generated 6384 euros. These costs were higher than those of the other mental disorders studied. About one quarter of the costs could be attributed to comorbidity. Agoraphobia was associated with higher costs. LIMITATIONS: Methodological choices influence cost estimates. In the present study most of these will result in conservative cost estimates. CONCLUSIONS: Panic thus causes substantial societal costs. Given the availability of effective treatment, treatment may not only benefit individual patients, but also have economic returns for society.
BACKGROUND: Data on the societal costs of mental disorders are necessary to inform health policies. METHODS: This study assessed the costs of panic disorder and subthreshold panic disorder, compared these with costs of other mental disorders, and assessed the effects of (psychiatric and somatic) comorbidity and agoraphobia on the costs of panic. Using a large, population-based study in The Netherlands (n=5504), both medical and production costs were estimated from a societal perspective within a one-year timeframe. RESULTS: Annual per capita costs of panic disorder were 10,269 euros, while subthreshold panic disorder generated 6384 euros. These costs were higher than those of the other mental disorders studied. About one quarter of the costs could be attributed to comorbidity. Agoraphobia was associated with higher costs. LIMITATIONS: Methodological choices influence cost estimates. In the present study most of these will result in conservative cost estimates. CONCLUSIONS: Panic thus causes substantial societal costs. Given the availability of effective treatment, treatment may not only benefit individual patients, but also have economic returns for society.
Authors: Thomas Dresler; Anne Guhn; Sara V Tupak; Ann-Christine Ehlis; Martin J Herrmann; Andreas J Fallgatter; Jürgen Deckert; Katharina Domschke Journal: J Neural Transm (Vienna) Date: 2012-06-13 Impact factor: 3.575
Authors: William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre Journal: Epidemiol Rev Date: 2008-09-19 Impact factor: 6.222
Authors: Dianne L Chambless; Barbara Milrod; Eliora Porter; Robert Gallop; Kevin S McCarthy; Elizabeth Graf; Marie Rudden; Brian A Sharpless; Jacques P Barber Journal: J Consult Clin Psychol Date: 2017-06-26
Authors: Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker Journal: BMC Psychiatry Date: 2014-07-02 Impact factor: 3.630
Authors: Kamila S White; Laura A Payne; Jack M Gorman; M Katherine Shear; Scott W Woods; John R Saksa; David H Barlow Journal: J Consult Clin Psychol Date: 2012-11-05
Authors: Filip Smit; Godelief Willemse; Peter Meulenbeek; Marc Koopmanschap; Anton van Balkom; Philip Spinhoven; Pim Cuijpers Journal: Cost Eff Resour Alloc Date: 2009-04-24